Two Sigma Investments’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.6M Sell
1,369,149
-191,116
-12% -$1.71M 0.01% 1200
2025
Q4
$13.2M Buy
1,560,265
+464,630
+42% +$3.32M 0.02% 953
2025
Q3
$5.72M Buy
1,095,635
+72,251
+7% +$276K 0.01% 1340
2025
Q2
$3.54M Buy
1,023,384
+179,528
+21% +$534K 0.01% 1453
2025
Q1
$2.21M Buy
843,856
+27,771
+3% +$109K ﹤0.01% 1669
2024
Q4
$3.36M Sell
816,085
-199,482
-20% -$1.09M 0.01% 1371
2024
Q3
$7.19M Buy
1,015,567
+285,545
+39% +$2.13M 0.02% 906
2024
Q2
$4.76M Buy
730,022
+142,332
+24% +$973K 0.01% 1029
2024
Q1
$4.88M Buy
587,690
+182,774
+45% +$1.78M 0.01% 986
2023
Q4
$4.46M Buy
404,916
+4,243
+1% +$35.8K 0.01% 1056
2023
Q3
$3.37M Buy
+400,673
New +$4.31M 0.01% 1092
2022
Q3
Sell
-23,909
Closed -$400K 2770
2022
Q2
$400K Buy
+23,909
New +$512K ﹤0.01% 1905
2021
Q4
Sell
-191,891
Closed -$6.05M 4933
2021
Q3
$6.05M Buy
+191,891
New +$6.46M 0.02% 1099

Other funds holding RLAY